tillysims's blog posts
Postdoctoral Fellow, Wellcome Trust Sanger Institute Dr George Vassiliou & Dr Brian Huntly This opening offers an exciting opportunity to study the pathogenesis of myeloid leukaemia using state-of-the-art model systems under the joint supervision of Dr George Vassiliou (Sanger Institute) and Dr Brian Huntly (University of Cambridge) as part of Leukaemia & Lymphoma Research’s Specialist Programme funding.
Blog Kat Macaulay's story
“My name is Kat Macaulay. I'm 32 and I have stage two Hodgkin lymphoma. I started chemotherapy, using a combination of drugs called ABVD on Friday 12 August. “I found a lump in my neck in April but hadn't realised until I saw a photo that I'd had it for a good few months longer. I had felt quite tired and had experienced itchy skin but those were the only other symptoms that I'd experienced.
Blog How we're beating leukaemia
Around 7,000 adults are diagnosed with leukaemia in the UK every year. Leukaemia & Lymphoma Research currently has more than £30 million invested in world-class research across the UK to develop better treatments and cures for patients with this type of blood cancer. This includes pioneering research to develop new less toxic treatments, ground-breaking clinical trials and state-of-the-art stem cell research.
Blog How we're beating myeloma
Around 4,000 people are diagnosed with myeloma in the UK every year. At present there is no permanent cure for this blood cancer, but treatments are fast improving. Leukaemia & Lymphoma Research is currently investing around £4 million into research across the UK to find new and better treatments for people touched by myeloma. This includes leading research to develop new drugs that prevent and repair bone damage caused by myeloma, state of the art stem cell research and ground breaking clinical trials.
Blog How we're beating lymphoma
Lymphoma is the most common form of blood cancer in teenagers and young adults aged between 15 and 35 years. Around 12,000 adults, children and teenagers are diagnosed with lymphoma, including Hodgkin lymphoma, in the UK every year. Leukaemia & Lymphoma Research is currently investing more than £10million into research across the UK to improve treatments and minimise the long-term side effects, for patients touched by these blood cancers.
Blog Harvey Greenwood's story
This new drug was my only shot "I was diagnosed with chronic myeloid leukaemia (CML) in 2001, aged only 30 years. "My chances of survival were low and I'm not afraid to say it was the most frightening time of my life. "A life-saving stem cell transplant was not an option as I was unlikely to find a good donor match and there was no other cure.